Researchers at the Max Planck Institute for Intelligent Systems and their collaborators have made a breakthrough in nanomotors for future applications in medicine by developing the first ever fully biocompatible self-propelling particles that are powered by enzymes that consume biological fuels, such as glucose.
In a study published today in Nanoletters, Max Planck research group leader and ICREA research professor Samuel Sánchez and his collaborators at the University of Tübingen and the MPI for Solid State Research, Germany, describe their fabrication of the world’s first enzyme-powered synthetic nanomotors that overcome the disadvantages of current systems by being both biocompatible and powered by biologically benign fuels.
The new bio-friendly mini motors, which are made from hollow mesoporous silica proven to be harmless to cells and tissues, will be able to be used in biomedical applications, as their self-propulsion is powered by the biocatalytic reactions of three different naturally occurring enzymes: catalase, urease, and glucose oxidase. The enzymatic reactions power the Janus nanoparticles – special types whose surfaces have two or more distinct physical properties – by occurring asymmetrically on only one surface, propelling them in the opposite direction. Not only that, but the researchers based in Tübingen also broke new ground during this study by measuring, for the first time, the propulsion force of nanomotors using optical tweezers, leading to a better understanding of how self-propelled nanoparticles behave.
“To be safe for use in applications in medicine in the body, nanoparticles need to be made out of biocompatible and biodegradable materials, as well as being capable of both autonomous motion using biologically benign fuels and cargo delivery – such as drug delivery – at small scales,” says Samuel, who heads what has been described as ‘one of the leading groups in the field’ of nanomotor research, the Smart Nano-Bio-Devices group, with locations at the Max Planck Institute for Intelligent Systems (MPI-IS) in Stuttgart and at the Institute for Bioengineering of Catalonia (IBEC) in Barcelona. “We’ve tackled all these issues with our new particles. For their architecture, we used a material which offers a high drug-loading capacity owing to its hollow structure; and for propulsion, we based our methods on the quite recent discovery that enzymes by themselves can act as self-propelled nanomotors as well as being anchored to larger artificial objects, such as carbon nanotubes, to provide a propulsion force using catalytic reactions.”
Such biocatalytic reactions triggered by enzymes consume non-toxic ‘fuel’, as they are naturally present in a biological environment.Different enzyme/fuel combinations can also be used, such as catalase and hydrogen peroxide or glucose and glucose oxidase, meaning the method is very versatile with the potential to be extended to further enzymes.
Previous active micro-and nanosystems developed for potential biomedical uses – as carriers of drug molecules to targeted sites, for example – were limited when it came to real applications because their usual methods of propulsion, such as the decomposition of hydrogen peroxide and platinum, were short-lived and harsh; others were simply passive nanosystems, unable to move autonomously. Additionally, these nanomotors are for first time made up of non-metallic components but only made of silica and enzymes, which assures their biocompatibility and potential biodegradation .
The next steps for the researchers will be to explore how to increase the effective driving force and guide their bio-friendly nanomotors by external manipulation methods, such as chemotaxis, magnetic control or ultrasound, leading to directional movement for active drug delivery to specific locations.
The Max Planck Institute for Intelligent Systems with locations in Stuttgart and Tübingen emerged in 2011 from the Max Planck Institute for Metals Research in Stuttgart. In eight departments, scientists conduct research in the fields of materials science, computer science and biology.
Annette Stumpf | Max-Planck-Institut für Intelligente Systeme
What happens in the cell nucleus after fertilization
06.12.2016 | Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt
Researchers uncover protein-based “cancer signature”
05.12.2016 | Universität Basel
In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.
Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...
Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...
A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.
Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...
In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.
“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...
The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.
The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...
16.11.2016 | Event News
01.11.2016 | Event News
14.10.2016 | Event News
06.12.2016 | Power and Electrical Engineering
06.12.2016 | Earth Sciences
06.12.2016 | Physics and Astronomy